Skip to main content Back to Top

GLP Practice Insights: GLP-1 Receptor Agonists and Bone Mineral Density (CE)

October 17, 2026


ABOUT THIS PODCAST

This activity explores emerging evidence on the relationship between GLP-1 receptor agonists therapy and bone mineral density. As the use of these agents expands across chronic disease states, pharmacists must understand their potential impact on bone health to support comprehensive patient care and risk mitigation.


SPEAKERS

  • Emily Doycich, PharmD, BCPS
    Ambulatory Care Pharmacy Specialist
  • Elise McCuiston, PharmD
    Ambulatory Care Pharmacy Specialist

LISTEN ON


iTunes      Google            Spotify      TuneIn      iHeart Radio


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Podcasts